Surgery Partners, Inc. Forecast, price target & analysts
Surgery Partners, Inc. Target price 2025 - Analyst rating & recommendation
Surgery Partners, Inc. Classifications & Recommendation:
Surgery Partners, Inc. Price Target
| Target Price | $32.64 |
| Price | $19.74 |
| Potential |
65.35%
register free of charge
|
| Number of Estimates | 13 |
|
13 Analysts have issued a price target Surgery Partners, Inc. 2026 .
The average Surgery Partners, Inc. target price is $32.64.
This is
65.35%
register free of charge
$37.80
91.49%
register free of charge
$24.24
22.80%
register free of charge
|
|
| A rating was issued by 18 analysts: 14 Analysts recommend Surgery Partners, Inc. to buy, 4 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Surgery Partners, Inc. stock has an average upside potential 2026 of
65.35%
register free of charge
|
Sales and Margin forecast 2025, 2026 to 2029
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Billion $ | 3.11 | 3.42 |
| 13.52% | 9.85% | |
| EBITDA Margin | 20.13% | 16.91% |
| 3.61% | 15.99% | |
| Net Margin | -5.40% | 3.33% |
| 1,144.32% | 161.69% |
14 Analysts have issued a sales forecast Surgery Partners, Inc. 2025 . The average Surgery Partners, Inc. sales estimate is
This results in the following potential growth metrics:
14 Analysts have issued an Surgery Partners, Inc. EBITDA forecast 2025. The average Surgery Partners, Inc. EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
14 Surgery Partners, Inc. Analysts have issued a net profit forecast 2025. The average Surgery Partners, Inc. net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2029
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -1.33 | 0.89 |
| 1,377.78% | 166.92% | |
| P/E | 22.19 | |
| EV/Sales | 1.71 |
14 Analysts have issued a Surgery Partners, Inc. forecast for earnings per share. The average Surgery Partners, Inc. EPS is
This results in the following potential growth metrics and future valuations:
Surgery Partners, Inc....
Current Surgery Partners, Inc. Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Cantor Fitzgerald |
Locked
➜
Locked
|
Locked | Oct 07 2025 |
| Barclays |
Locked
➜
Locked
|
Locked | May 27 2025 |
| Benchmark |
Locked
➜
Locked
|
Locked | Apr 21 2025 |
| RBC Capital |
Locked
➜
Locked
|
Locked | Mar 25 2025 |
| Macquarie |
Locked
➜
Locked
|
Locked | Mar 11 2025 |
| JP Morgan |
Locked
➜
Locked
|
Locked | Dec 03 2024 |
| RBC Capital |
Locked
➜
Locked
|
Locked | Nov 20 2024 |
| Analyst Rating | Date |
|---|---|
|
Locked
Cantor Fitzgerald:
Locked
➜
Locked
|
Oct 07 2025 |
|
Locked
Barclays:
Locked
➜
Locked
|
May 27 2025 |
|
Locked
Benchmark:
Locked
➜
Locked
|
Apr 21 2025 |
|
Locked
RBC Capital:
Locked
➜
Locked
|
Mar 25 2025 |
|
Locked
Macquarie:
Locked
➜
Locked
|
Mar 11 2025 |
|
Locked
JP Morgan:
Locked
➜
Locked
|
Dec 03 2024 |
|
Locked
RBC Capital:
Locked
➜
Locked
|
Nov 20 2024 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
